Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at DKK 588.9B, ahead of Johnson & Johnson (DKK 555.3B) and Sanofi (DKK 539.3B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerDKK 588.9B
- Median
- DKK 6B
- Combined market value
- DKK 35.03T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | DKK 588.9B | DKK 1.1T | DKK 193.83 | 0.02% up | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | DKK 555.3B | DKK 4.56T | DKK 1,895.62 | 0.16% down | 38% up | ||
| 3 | SanofiSNY · Health Care | DKK 539.3B | DKK 777.5B | DKK 323.79 | 0.04% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | DKK 358.2B | DKK 2.36T | DKK 957.48 | 1.95% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | DKK 355B | DKK 1.23T | DKK 712.99 | 0.05% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | DKK 331.4B | DKK 1.91T | DKK 1,231.66 | 0.74% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | DKK 316.8B | DKK 468.3B | DKK 146.57 | 0.55% down | 54% up | ||
| 8 | NovartisNVS · Health Care | DKK 314.1B | DKK 2.03T | DKK 1,072.90 | 1.01% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | DKK 212.8B | DKK 679.7B | DKK 6,570.26 | 0.74% up | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | DKK 196.1B | DKK 1.21T | DKK 274.80 | 0.86% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | DKK 180.7B | DKK 8.59T | DKK 9,647.81 | 0.10% up | 35% up | ||
| 12 | GSKGSK · Health Care | DKK 148B | DKK 671.8B | DKK 335.16 | 0.01% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | DKK 127.1B | DKK 924.3B | DKK 3,645.80 | 0.22% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | DKK 125.8B | DKK 848.1B | DKK 414.90 | 0.73% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | DKK 100.2B | DKK 160.8B | DKK 140.24 | 0.71% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | DKK 66.2B | DKK 269.5B | DKK 468.76 | 0.23% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 53.9B | DKK 340.1B | DKK 291.51 | 0.47% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | DKK 48.3B | DKK 169.4B | DKK 3,978.47 | 0.03% up | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | DKK 44.6B | DKK 89.9B | DKK 179.84 | 2.17% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | DKK 41.4B | DKK 77.8B | DKK 401.62 | 0.80% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | DKK 39.8B | DKK 40B | DKK 58.77 | 0.00% | 1% up | ||
| 22 | GenmabGMAB · Health Care | DKK 39.8B | DKK 218B | DKK 353.62 | 0.06% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | DKK 30.8B | DKK 191.7B | DKK 264.60 | 0.38% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | DKK 29.7B | DKK 318.6B | DKK 2,789.57 | 0.87% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 29.4B | DKK 105B | DKK 1,636.22 | 0.18% down | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 27.3B | DKK 84.8B | DKK 101.73 | 0.95% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | DKK 22.7B | DKK 232.6B | DKK 572.47 | 0.71% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | DKK 12.4B | DKK 52.9B | DKK 314.56 | 1.64% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | DKK 6.9B | DKK 40.5B | DKK 2,024.25 | 1.18% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | DKK 6.8B | DKK 22.2B | DKK 114.33 | 4.22% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | DKK 6B | DKK 58.1B | DKK 2,078.46 | 0.06% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | DKK 5.4B | DKK 142.7B | DKK 1,065.07 | 0.06% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | DKK 5.2B | DKK 43.6B | DKK 1,073.99 | 0.00% | 31% up | ||
| 34 | InsmedINSM · Health Care | DKK 5B | DKK 182.4B | DKK 831.30 | 0.18% up | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | DKK 4.9B | DKK 61.4B | DKK 646.19 | 1.16% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | DKK 4.5B | DKK 57.5B | DKK 71.87 | 1.08% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | DKK 4.4B | DKK 65.3B | DKK 432.22 | 1.22% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | DKK 4.4B | DKK 52.7B | DKK 481.12 | 0.83% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | DKK 4.3B | DKK 33.5B | DKK 192.64 | 1.58% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | DKK 4.2B | DKK 56B | DKK 857.65 | 1.03% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.1B | DKK 66.5B | DKK 2,863.25 | 0.36% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 3.9B | DKK 51.5B | DKK 656.06 | 1.30% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | DKK 3.6B | DKK 31.5B | DKK 287.60 | 0.46% up | 88% up | ||
| 44 | ABIVAXABVX · Health Care | DKK 3.4B | DKK 49.6B | DKK 566.28 | 1.29% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | DKK 3.4B | DKK 33.5B | DKK 594.40 | 0.36% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | DKK 3.3B | DKK 31.2B | DKK 187.26 | 2.00% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | DKK 3.2B | DKK 45.6B | DKK 672.40 | 2.52% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 3.2B | DKK 41.5B | DKK 293.39 | 0.22% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | DKK 2.3B | DKK 27.5B | DKK 200.68 | 0.31% up | 169% up | ||
| 50 | ErascaERAS · Health Care | DKK 2.2B | DKK 33B | DKK 94.04 | 0.58% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | DKK 2.1B | DKK 40.7B | DKK 623.27 | 0.46% down | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 947M | DKK 54.7B | DKK 789.29 | 0.60% down | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | DKK 781.9M | DKK 33.3B | DKK 347.15 | 0.23% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | DKK 601.2M | DKK 48.9B | DKK 930.31 | 0.49% up | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -DKK 482.1M | DKK 50.8B | DKK 145.77 | 1.36% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -DKK 824M | DKK 36.3B | DKK 861.16 | 0.46% up | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -DKK 1.2B | DKK 121.1B | DKK 1,845.64 | 0.06% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -DKK 1.4B | DKK 34.3B | DKK 410.10 | 0.22% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -DKK 4.5B | DKK 49.4B | DKK 354.47 | 0.78% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -DKK 14.2B | DKK 102.2B | DKK 524.47 | 0.29% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -DKK 22.3B | DKK 3.51T | DKK 1,985.85 | 0.42% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8095 DKK).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (DKK 588.9B), Johnson & Johnson (DKK 555.3B) and Sanofi (DKK 539.3B) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of DKK 35.03T as of 18 Nov 2026, 14:39 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.